DUBLIN–(BUSINESS WIRE)–The “Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025” report has been added to ResearchAndMarkets.com’s offering.
The global pharmaceuticals, biopharmaceuticals, and neutraceuticals market includes market revenues of analytical instrumentation applied in the 3 segments. Analytical instruments are applied in research, development, manufacturing, quality control, and distribution of drugs. Some key applications include (and are not limited to) drug discovery and development testing, biopharmaceutical analytical testing, quality control testing, cancer research, and process technology analysis.
Neutraceutical includes analytical equipment used for functional food and beverages, dietary supplements, and herbals. Geographic scope is global. Different techniques, including chromatographs, mass spectrometers, infrared spectrometers, UV-Vis spectrometers, Raman spectrometers, thermal analyzers, and X-ray diffractometers are included under different applications.
Market Highlights
The total analytical instrumentation market in pharmaceuticals, biopharmaceuticals, and neutraceuticals was estimated at $3,056.7 million in 2018 and is expected to reach $4,911.4 million in 2025. There is a high pricing pressure on drug manufacturers to cut down costs. Hence, manufacturers would have to create a flexible pricing strategy to maximize their profits and negotiate with payers. Process analyzers that can be plugged in as part of the manufacturing process would reduce operating costs for manufacturers.
The pharmaceutical market in 2018 oversaw massive vertical integration of organizations. This would lead to cost efficiency and innovation in the industry.
Asia-Pacific is a large focus for pharmaceutical manufacturers, especially China. China has become a hub for innovation and R&D.
With the increasing approval for biosimilars in the United States, there would be significant cost cuts in the country, motivated by government institutions such as the National Health Service (NHS). The price differential between biosimilars and their branded counterparts is 30%. US political uncertainty and Brexit would negatively impact pharmaceutical market growth.
Manufacturers are offering exclusive biopharmaceutical solutions to resolve challenges associated with biological drugs. The intention of avoiding side effects-imposing small molecules and complex surgical procedures has led to targeted therapies of biologics. By 2020, analysts will expect biological drugs to capture about a quarter of the total small molecules market.
The growth of biological drugs is expected to continue, as biological blockbuster drugs keep entering the market. The penetration of biologic drugs will increase from 25% in 2016 to 30% in 2022.
Neutraceuticals are gaining importance and becoming a part of consumers’ daily diet. Lifestyle, health disorders, and lack of exercise are leading to the segment’s growth. Ingredients and raw material contamination, less awareness, and unclear regulations are challenging market growth.
Neutraceuticals are often dietary supplements or food additives. They offer benefits such as preventing and curing diseases. Functional beverages such as energy drinks that contain stimulants to make the brain active are also popular.
Key Topics Covered
1 Executive Summary
- Key Findings
- Market Engineering Measurements
- CEO’s Perspective
2 Market Overview
- Market Scope and Definitions
- Key Questions this Study will Answer
- Market Segmentation
3 Drivers and Restraints – Total Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Neutraceuticals
- Market Drivers
- Drivers Explained
- Market Restraints
- Restraints Explained
4 Forecasts and Trends – Total Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Neutraceuticals
- Market Engineering Measurements
- Forecast Assumptions
- Revenue Forecast
- Revenue Forecast Discussion
- Pricing Analysis
- Percent Revenue Forecast by Region
- Revenue Forecast by Region
- Top Trends in North America
- Top Trends in Europe
- Top Trends in Asia-Pacific
- Top Trends in RoW
- Revenue Forecast by Vertical Market
- Top Competitors
- Product Highlights
5 Growth Opportunities and Companies to Action
- Growth Opportunity 1 – Neutraceuticals
- Growth Opportunity 2 – Biosimilars
- Strategic Imperatives for Success and Growth
6 Pharmaceutical Segment Analysis
- Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion
- Revenue Forecast by Product
- Revenue Forecast Discussion by Product
- Market Share
- Market Share Analysis
- Competitive Environment
7 Biopharmaceutical Segment Analysis
- Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion
- Revenue Forecast by Product
- Revenue Forecast Discussion by Product
- Market Share
- Market Share Analysis
- Competitive Environment
8 Neutraceuticals Segment Analysis
- Key Findings
- Market Engineering Measurements
- Revenue Forecast
- Revenue Forecast Discussion
- Revenue Forecast by Product
- Revenue Forecast Discussion by Product
- Market Share
- Market Share Analysis
- Competitive Environment
9 India Breakdown
- Key Findings
- Revenue Forecast
- Revenue Forecast Discussion
- Revenue Forecast by Vertical Market
- Revenue Forecast Discussion by Vertical Market
- Market Segmentation – Pharmaceuticals
- Market Segmentation – Biopharmaceuticals
- Market Segmentation – Neutraceuticals
- Market Share
- Market Share Analysis
- Competitive Environment
10 The Last Word
- The Last Word – 3 Big Predictions
For more information about this report visit https://www.researchandmarkets.com/r/cjgdam
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900